189 related articles for article (PubMed ID: 26871579)
41. Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink.
Bannon FJ; O'Rorke MA; Murray LJ; Hughes CM; Gavin AT; Fleming SJ; Cardwell CR
Cancer Causes Control; 2013 Nov; 24(11):2027-34. PubMed ID: 23990380
[TBL] [Abstract][Full Text] [Related]
42. HMG CoA reductase inhibitors, NSAIDs and risk of glioma.
Ferris JS; McCoy L; Neugut AI; Wrensch M; Lai R
Int J Cancer; 2012 Sep; 131(6):E1031-7. PubMed ID: 22419506
[TBL] [Abstract][Full Text] [Related]
43. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and predictors of non-steroidal anti-inflammatory drug/analgesic therapeutic duplication in the South Korean ambulatory care setting.
Kang HA; Lee SM; Park C; Kim DS
Eur J Clin Pharmacol; 2016 Jan; 72(1):109-16. PubMed ID: 26490355
[TBL] [Abstract][Full Text] [Related]
45. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
46. Use of tricyclic antidepressants and risk of glioma: a nationwide case-control study.
Pottegård A; García Rodríguez LA; Rasmussen L; Damkier P; Friis S; Gaist D
Br J Cancer; 2016 May; 114(11):1265-8. PubMed ID: 27115466
[TBL] [Abstract][Full Text] [Related]
47. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
48. Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan.
Hsiang KW; Chen TS; Lin HY; Luo JC; Lu CL; Lin HC; Lee KC; Chang FY; Lee SD
Clin Ther; 2010 Jul; 32(7):1294-303. PubMed ID: 20678677
[TBL] [Abstract][Full Text] [Related]
49. Association between prediagnostic IgE levels and risk of glioma.
Schwartzbaum J; Ding B; Johannesen TB; Osnes LT; Karavodin L; Ahlbom A; Feychting M; Grimsrud TK
J Natl Cancer Inst; 2012 Aug; 104(16):1251-9. PubMed ID: 22855780
[TBL] [Abstract][Full Text] [Related]
50. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs.
Castellsague J; Holick CN; Hoffman CC; Gimeno V; Stang MR; Perez-Gutthann S
Pharmacotherapy; 2009 Dec; 29(12):1397-407. PubMed ID: 19947799
[TBL] [Abstract][Full Text] [Related]
51. Postoperative nonsteroidal antiinflammatory drugs and the prevention of heterotopic ossification after cervical arthroplasty: analysis using CT and a minimum 2-year follow-up.
Tu TH; Wu JC; Huang WC; Chang HK; Ko CC; Fay LY; Wu CL; Cheng H
J Neurosurg Spine; 2015 May; 22(5):447-53. PubMed ID: 25723121
[TBL] [Abstract][Full Text] [Related]
52. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
53. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.
Daniel S; Matok I; Gorodischer R; Koren G; Uziel E; Wiznitzer A; Levy A
J Rheumatol; 2012 Nov; 39(11):2163-9. PubMed ID: 22984274
[TBL] [Abstract][Full Text] [Related]
54. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.
Andersohn F; Suissa S; Garbe E
Circulation; 2006 Apr; 113(16):1950-7. PubMed ID: 16618816
[TBL] [Abstract][Full Text] [Related]
55. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
[TBL] [Abstract][Full Text] [Related]
56. Trends in incidence of primary brain cancer in New Zealand, 1995 to 2010.
Kim SJ; Ioannides SJ; Elwood JM
Aust N Z J Public Health; 2015 Apr; 39(2):148-52. PubMed ID: 25715883
[TBL] [Abstract][Full Text] [Related]
57. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
Hippisley-Cox J; Coupland C; Logan R
BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
[TBL] [Abstract][Full Text] [Related]
58. Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.
Klein M
Dan Med J; 2012 Mar; 59(3):B4420. PubMed ID: 22381097
[TBL] [Abstract][Full Text] [Related]
59. Risk of perioperative bleeding related to highly selective cyclooxygenase-2 inhibitors: A systematic review and meta-analysis.
Teerawattananon C; Tantayakom P; Suwanawiboon B; Katchamart W
Semin Arthritis Rheum; 2017 Feb; 46(4):520-528. PubMed ID: 27569276
[TBL] [Abstract][Full Text] [Related]
60. Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study.
Wu CW; Wu JY; Lee MG; Lai CC; Wu IL; Tsai YW; Chang SS; Lee CC
BMC Pulm Med; 2017 May; 17(1):82. PubMed ID: 28472944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
